Trial intelligence / Profile preview

Epidural Nalbuphine for Prevention of Morphine Induced Pruritus

NCT00707824Phase 4Completed

Sponsor
Mahidol University
Start
Jun 2000
Primary completion
Dec 2005
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of nalbuphine in pruritus (3 arms), sponsored by Mahidol University. Primary endpoints: Incidence of postoperative pruritus at 24 hours and Severity of postoperative pruritus at 24 hours. Started Jun 2000; status: completed.

02

Drugs

nalbuphine
03

Conditions

pruritus

Beyond the preview

Go deeper on NCT00707824.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00707824.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call